Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

3D-Tissue Engineered Bone Marrow (3DTEBM) Culture Retrospectively Predicts Treatment Clinical Outcomes of Multiple Myeloma Patients

Amanda Jeske, BS, Feda Azab, BPharm, Pilar De La Puente, PhD, Barbara Muz, PhDMSc, Justin King, Daniel R. Kohnen, MBA, Ravi Vij, MBBS, Abdel Kareem Azab, PhD

Blood (2018) 132 (Supplement 1): 1987.

https://doi.org/10.1182/blood-2018-99-118888

Published: 2018

Journal Articles

Tris DBA Palladium Overcomes Hypoxia Mediated Drug Resistance in Multiple Myeloma

Pilar De La Puente, PhD, Barbara Muz, PhDMSc, Feda Azab, BPharm, Micah John Luderer, BS, MS, Jack L. Arbiser, MD, PhD, Abdel Kareem Azab, BPharm, PhD

Blood (2015) 126 (23): 2978.

https://doi.org/10.1182/blood.V126.23.2978.2978

Published: 2015

Journal Articles

Hypoxia Induces Pgp-Mediated Carfilzomib Resistance in Multiple Myeloma Cells and HIF Inhibition Significantly Enhances Sensitivity and Response to Carfilzomib In Vivo

Barbara Muz, PhDMSc, Joseph Abraham, Feda Azab, BPharm, Pilar De La Puente, PhD, Nicholas Potter, Benjamin Minch, Farideh Ordikhani, Noha Salama, Abdel Kareem Azab, BPharm, PhD

Blood (2015) 126 (23): 1286.

https://doi.org/10.1182/blood.V126.23.1286.1286

Published: 2015

Journal Articles

Novel Method to Detect Minimal Residual Disease in Multiple Myeloma Predicts Recurrence Better Than CD138-Based Models

Barbara Muz, PhDMSc, Feda Azab, BPharm, Pilar De La Puente, PhD, Justin King, Micah John Luderer, BS, MS, Ravi Vij, MD MBA, Abdel Kareem Azab, BPharm, PhD

Blood (2015) 126 (23): 2985.

https://doi.org/10.1182/blood.V126.23.2985.2985

Published: 2015

Journal Articles

Selinexor Is an Effective Cancer Treatment in Hypoxic Conditions and Synergizes with Proteasome Inhibitors to Treat Drug Resistant Multiple Myeloma

Barbara Muz, PhDMSc, Feda Azab, BPharm, Pilar De La Puente, PhD, Yosef Landesman, PhD, Abdel Kareem Azab, BPharm, PhD

Blood (2015) 126 (23): 3017.

https://doi.org/10.1182/blood.V126.23.3017.3017

Published: 2015

Journal Articles

CXCR4 Monoclonal Antibody, BMS-936564 (MDX-1338), Modulates Epithelial to Mesenchymal Transition (EMT) in Multiple Myeloma Cells

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Michelle R. Kuhne, PhD, Abdel Kareem Azab, PhD, BSPharm, Patricia Maiso, PhD, Feda Azab, BPharm, Salomon Manier, MD, Yosra Aljaway, BS, Michaela R Reagan, PhD, Lewis Cohen, MD, MS, Pina M Cardarelli, Ph.D., Irene M. Ghobrial, MD

Blood (2012) 120 (21): 4009.

https://doi.org/10.1182/blood.V120.21.4009.4009

Published: 2012

Journal Articles

Hypoxia Promotes Dissemination of Multiple Myeloma Through Acquisition of Endothelial to Mesenchymal Transition (EMT) Features

Abdel Kareem Azab, PhD, BSPharm, Jinsong Hu, Phong Quang, BS, Feda Azab, BPharm, Costas Pitsillides, Brian Thompson, Patricia Maiso, PhD, Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Hai T Ngo, BS, Ghayas C. Issa, MD, Charles Lin, PhD, Andrew L. Kung, MD, PhD, Karin Vanderkerken, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 471.

https://doi.org/10.1182/blood.V118.21.471.471

Published: 2011

Journal Articles

Stroma-Derived Exosomes Mediate Oncogenesis in Multiple Myeloma

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Abdel Kareem Azab, PhD, Yu-Tzu Tai, PhD, Patricia Maiso, PhD, Yong Zhang, PhD, Yang Liu, PhD, Michaela Reagan, PhD, Feda Azab, BPharm, Ghayas C Issa, MD, Hai T Ngo, BS, Phong Quang, BS, Kenneth C Anderson, MD, Riccardo Dalla-Favera, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 625.

https://doi.org/10.1182/blood.V118.21.625.625

Published: 2011

Journal Articles

L-Stereoisomer RNA Oligonucleotide Anti-SDF-1 (Nox-A12) Disrupts the Interaction of Multiple Myeloma Cells with the Bone Marrow Milieu In Vivo , Leading to Enhanced Sensitivity to Bortezomib

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Phong Quang, BS, AbdelKareem Azab, PhD, Patricia Maiso, PhD, Feda Azab, BPharm, Yong Zhang, PhD, Ghayas C Issa, MD, Yang Liu, PhD, Hai T Ngo, BS, Anna Kruschinski, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 887.

https://doi.org/10.1182/blood.V118.21.887.887

Published: 2011

Journal Articles

Deregulation of TNFRSF18 (GITR) Through Promoter CpG Island Methylation Induces Tumor Proliferation in Multiple Myeloma

Yang Liu, PhD, Yong Zhang, PhD, Phong Quang, BS, Hai T Ngo, BS, Feda Azab, BPharm, Abdel Kareem Azab, PhD, BSPharm, Brittany Morgan, Patricia Maiso, PhD, Michaela Reagan, PhD, Christopher P. Rombaoa, Antonio Sacco, BS, Aldo M Roccaro, MD, PhD, Ruben Carrasco, MD, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 2424.

https://doi.org/10.1182/blood.V118.21.2424.2424

Published: 2011

Journal Articles

LNA Anti-MicroRNA-155: A Novel Therapeutic Strategy in Waldenstrom Macroglobulinemia and Chronic Lymphocytic Leukemia

Blood (2011) 118 (21): 2728.

https://doi.org/10.1182/blood.V118.21.2728.2728

Published: 2011

Journal Articles

Dissecting the role of CXCR7 in Cell Trafficking of Endothelial-Cells and Endothelial-Progenitor-Cells in Multiple Myeloma,

Abdel Kareem Azab, PhD, BSPharm, Feda Azab, BPharm, Phong Quang, Patricia Maiso, PhD, Hai T Ngo, BS, Johann Zimmermann, Kalpana Patel, Barbara Romagnoli, Antonio Sacco, BS, Yang Liu, PhD, Yong Zhang, PhD, Michaela Reagan, PhD, Aldo M Roccaro, MD, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 3934.

https://doi.org/10.1182/blood.V118.21.3934.3934

Published: 2011

Journal Articles

MicroRNA-155 As a Potential Plasma Biomarker for Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia,

Christopher P. Rombaoa, Yong Zhang, PhD, Ranjit Banwait, MA, Yang Liu, PhD, Hai T Ngo, BS, Phong Quang, Abdel Kareem Azab, Bpharm, PhD, Feda Azab, BPharm, Patricia Maiso, PhD, Michaela Reagan, PhD, Antonio Sacco, BS, Aldo M Roccaro, MD, PhD, Jennifer R. Brown, MD, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 3669.

https://doi.org/10.1182/blood.V118.21.3669.3669

Published: 2011

Journal Articles

The Role of PI3K Signaling in Cell Trafficking of Multiple Myeloma

Feda Azab, BPharm, Abdel Kareem Azab, PhD, BSPharm, Patricia Maiso, PhD, Phong Quang, Hai T Ngo, BS, Antonio Sacco, BS, Yang Liu, PhD, Yong Zhang, PhD, Michaela Reagan, PhD, Aldo M Roccaro, MD, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 1804.

https://doi.org/10.1182/blood.V118.21.1804.1804

Published: 2011

Journal Articles

Role of TORC1 and TORC2 in Multiple Myeloma

Patricia Maiso, PhD, Yi Liu, PhD, Abdel Kareem Azab, PhD, BSPharm, Brittany Morgan, Feda Azab, BPharm, Antonio Sacco, BS, Michaela Reagan, PhD, Hai T Ngo, BS, Yang Liu, PhD, Yong Zhang, PhD, Charles Lin, PhD, Aldo M Roccaro, MD, PhD, Christian Rommel, PhD, Irene M. Ghobrial, MD

Blood (2011) 118 (21): 1815.

https://doi.org/10.1182/blood.V118.21.1815.1815

Published: 2011

Journal Articles

The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma

Aldo M Roccaro, MD, PhD, Antonio Sacco, BS, Michelle Kuhne, PhD, AbdelKareem Azab, PhD, Patricia Maiso, PhD, Yong Zhang, PhD, Yang Liu, PhD, Feda Azab, BPharm, Ghayas C Issa, MD, Phong Quang, BS, Hai T Ngo, BS, Chin Pan, Ph.D., Lew Choen, PhD, Pina M Cardarelli, Ph.D., Irene M. Ghobrial, MD

Blood (2011) 118 (21): 1844.

https://doi.org/10.1182/blood.V118.21.1844.1844

Published: 2011

Journal Articles

Citron Rho Interacting Kinase (CRIK) Regulates Survival in IL-6 Dependent Multiple Myeloma Cells.

Hai T. Ngo, Alexey A. Leontovich, PhD, Aldo M. Roccaro, MD, PhD, Abdel Kareem Azab, Bpharm, PhD, Judith M. Runnels, PhD, Feda Azab, BPharm, Antonio Sacco, Phong Quang, Kenneth C. Anderson, MD, Irene M. Ghobrial, M.D.

Blood (2009) 114 (22): 1825.

https://doi.org/10.1182/blood.V114.22.1825.1825

Published: 2009

Journal Articles

MicroRNA Changes Occur in Multiple Myeloma Cells in the Context of Bone Marrow Milieu.

Roccaro M. Roccaro, MD, PhD, Antonio Sacco, Abdel Kareem Azab, BPharm, PhD, Feda Azab, BPharm, Hai Ngo, Molly R Melhem, Phong Quong, Judith M. Runnels, PhD, Kenneth C. Anderson, MD, Irene Ghobrial, M.D.

Blood (2009) 114 (22): 1785.

https://doi.org/10.1182/blood.V114.22.1785.1785

Published: 2009

Journal Articles

Role of Selectins in the Pathogenesis of Multiple Myeloma.

Abdel Kareem Azab, Bpharm, PhD, Phong Quang, Feda Azab, BPharm, Costas M Pitsillides, John T Patton, Theodore Smith, Arun Sarkar, Judith M. Runnels, PhD, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Hai T. Ngo, Molly R Melhem, Patricia Maiso, PhD, Kenneth C. Anderson, MD, Charles P. Lin, PhD, John L. Magnani, Irene M. Ghobrial, M.D.

Blood (2009) 114 (22): 951.

https://doi.org/10.1182/blood.V114.22.951.951

Published: 2009

Journal Articles

Eph-B2 Receptor Tyrosine Kinase Is Overexpressed in Waldenstrom's Macroglubulinemia and Plays a Major Role in Its Interaction with the Bone Marrow Microenvironment.

Abdel Kareem Azab, Bpharm, PhD, Feda Azab, BPharm, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Phong Quang, Hai T. Ngo, Molly R Melhem, Judith M. Runnels, PhD, Patricia Maiso, PhD, Irene M. Ghobrial, M.D.

Blood (2009) 114 (22): 2935.

https://doi.org/10.1182/blood.V114.22.2935.2935

Published: 2009

NARROW

3D-Tissue Engineered Bone Marrow (3DTEBM) Culture Retrospectively Predicts Treatment Clinical Outcomes of Multiple Myeloma Patients

Tris DBA Palladium Overcomes Hypoxia Mediated Drug Resistance in Multiple Myeloma

Hypoxia Induces Pgp-Mediated Carfilzomib Resistance in Multiple Myeloma Cells and HIF Inhibition Significantly Enhances Sensitivity and Response to Carfilzomib In Vivo

Novel Method to Detect Minimal Residual Disease in Multiple Myeloma Predicts Recurrence Better Than CD138-Based Models

Selinexor Is an Effective Cancer Treatment in Hypoxic Conditions and Synergizes with Proteasome Inhibitors to Treat Drug Resistant Multiple Myeloma

CXCR4 Monoclonal Antibody, BMS-936564 (MDX-1338), Modulates Epithelial to Mesenchymal Transition (EMT) in Multiple Myeloma Cells

Hypoxia Promotes Dissemination of Multiple Myeloma Through Acquisition of Endothelial to Mesenchymal Transition (EMT) Features

Stroma-Derived Exosomes Mediate Oncogenesis in Multiple Myeloma

L-Stereoisomer RNA Oligonucleotide Anti-SDF-1 (Nox-A12) Disrupts the Interaction of Multiple Myeloma Cells with the Bone Marrow Milieu In Vivo , Leading to Enhanced Sensitivity to Bortezomib

Deregulation of TNFRSF18 (GITR) Through Promoter CpG Island Methylation Induces Tumor Proliferation in Multiple Myeloma

LNA Anti-MicroRNA-155: A Novel Therapeutic Strategy in Waldenstrom Macroglobulinemia and Chronic Lymphocytic Leukemia

Dissecting the role of CXCR7 in Cell Trafficking of Endothelial-Cells and Endothelial-Progenitor-Cells in Multiple Myeloma,

MicroRNA-155 As a Potential Plasma Biomarker for Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia,

The Role of PI3K Signaling in Cell Trafficking of Multiple Myeloma

Role of TORC1 and TORC2 in Multiple Myeloma

The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma

Citron Rho Interacting Kinase (CRIK) Regulates Survival in IL-6 Dependent Multiple Myeloma Cells.

MicroRNA Changes Occur in Multiple Myeloma Cells in the Context of Bone Marrow Milieu.

Role of Selectins in the Pathogenesis of Multiple Myeloma.

Eph-B2 Receptor Tyrosine Kinase Is Overexpressed in Waldenstrom's Macroglubulinemia and Plays a Major Role in Its Interaction with the Bone Marrow Microenvironment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only